All-transretinoic acid in the treatment of pediatric acute promyelocytic leukemia

Revisiting the differentiation paradigm in acute promyelocytic leukemia

(2011) J. Ablain et al.   BLOOD

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

(2011) M. Breccia et al.   BLOOD

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

(2011) G. Avvisati et al.   BLOOD

Genome-wide functions of PML–RARα in acute promyelocytic leukaemia

(2011) S Saeed et al.   BRITISH JOURNAL OF CANCER

Arsenic trioxide in acute promyelocytic leukemia: potion not poison

(2011) Bayard L Powell   Expert Review of Anticancer Therapy

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

(2010) M. A. Sanz et al.   BLOOD

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

(2010) M. S. Tallman et al.   BLOOD

BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia

(2010) Y. Yamamoto et al.   BLOOD

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

(2010) F. Lo-Coco et al.   BLOOD

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710

(2010) B. L. Powell et al.   BLOOD

Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses

(2010) Ursula Creutzig et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study

(2010) Masue Imaizumi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia

(2010) Steven D. Gore et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia

(2009) J. Zhou et al.   BLOOD

PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?

(2009) Nicola et al.   Frontiers in Bioscience-Landmark

Improved outcome for Chinese children with acute promyelocytic leukemia: A comparison of two protocols

(2009) Xue-Qun Luo et al.   PEDIATRIC BLOOD & CANCER

Treatment of children with acute promyelocytic leukemia: Results of the first North American intergroup trial INT0129

(2009) John Gregory et al.   PEDIATRIC BLOOD & CANCER

Acute promyelocytic leukemia in childhood

(2009) John Gregory et al.   Current Oncology Reports

Hematopoietic Stem Cell Transplant for Pediatric Acute Promyelocytic Leukemia

(2008) Christopher C. Dvorak et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

(2008) M. A. Sanz et al.   BLOOD

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

(2008) M. A. Sanz et al.   BLOOD

Ab therapy of AML: native anti-CD33 Ab and drug conjugates

(2008) J.G. Jurcic   CYTOTHERAPY

Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

(2008) Farhad Ravandi et al.   JOURNAL OF CLINICAL ONCOLOGY